21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthesis

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1299-1306

  Amin, Marli ^a   Simerman, Ariel ^a   Cho, Michele ^a   Singh, Prapti ^a   Briton Jones, Christine ^c   Hill, David ^c   Grogan, Tristan ^a   Elashoff, David ^a   Clarke, Nigel J ^b   Chazenbalk, Gregorio D ^a   Dumesic, Daniel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c ART Reproductive Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHOLESTEROL; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; GRANULOSA CELLS; HUMANS; IDEAL BODY WEIGHT; LIPID METABOLISM; LIPIDS; LUTEINIZATION; MINERALOCORTICOIDS; OVARIAN FOLLICLE; OVULATION INDUCTION; STEROID 21-HYDROXYLASE;

EID: 84898483828     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3204     Document Type: Article

References (40)

1. Azhar S, Tsai L, Medicherla S, Chandrasekher Y, Giudice L, Reaven E. Human granulosa cells use high density lipoprotein cholesterol for steroidogenesis. J Clin Endocrinol Metab. 1998;83:983-991.
2. Parinaud J, Perret B, Ribbes H, Chap H, Pontonnier G, Douste-Blazy L. High density lipoprotein and low density lipoprotein utilization by human granulosa cells for progesterone synthesis in serum-free culture: respective contributions of free and esterified cholesterol. J Clin Endocrinol Metab. 1987;64:409-417.
3. Rajan VP, Menon KM. Cholesterol flux between high density lipoproteins and cultured rat luteal cells. Endocrinology. 1989;124: 1857-1862.
4. Singh P, Amin M, Keller E, et al. A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF). J Assist Reprod Genet. 2013;30:733-740.
5. Salway JG. Metabolism at a Glance. 3rded. Malden, MA: Blackwell Publishing; 2010:72.
6. Conley AJ, Bird IM. The role of cytochrome P450 17a-hydroxylase and 3/3-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the 55-and 54 pathways of steroidogenesis in mammals. Biol Reprod. 1997;56:789-7997.
7. Fru KN, VandeVoort CA, Chaffin CL. Mineralocorticoid synthesis during the periovulatory interval in macaques. Biol Reprod. 2006; 75:568-574.
8. Sneeringer R, Penzias AS, Barrett B, Usheva A. High levels of min-eralocorticoids in preovulatory follicular fluid could contribute to oocyte development. Fertil Steril. 2011;95:182-187.
9. Nakamura E, Otsuka F, Inagaki K, et al. A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells. Endocrinology. 2010; 151:5506-5518.
10. Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference. Acta Obstet Gynecol Scand. 2011;90:1232-1238.
11. Qublan HS, Amarin Z, Tahat YA, Smadi AZ, Kilani M. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Hum Reprod. 2006;21:640-644.
12. Dumesic DA, Lesnick TG, Abbott DH. Increased adiposity enhances intrafollicular estradiol levels in normoandrogenic ovulatory women receiving gonadotropin-releasing hormone analog/recom-binant human follicle-stimulating hormone therapy for in vitro fertilization. J Clin Endocrinol Metab. 2007;92:1438-1441.
13. Robker RL, Wu LL, Yang X. Inflammatory pathways linking obe-sity and ovarian dysfunction. J Reprod Immunol. 2011;88:142-148.
14. Shamonki MI, Spandorfer SD, Rosenwaks Z. Ultrasound-guided embryo transfer and the accuracy of trial embryo transfer. Hum Reprod. 2005;20:709-716.
15. Dumesic DA, Lesnick TG, Stassart JP, Ball GD, Wong A, Abbott DH. Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandro-genic ovulatory women undergoing gonadotropin releasing-hor-mone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril. 2009;92:217-221.
16. Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosen-waks Z. Stimulation ofthe youngpoor responder: comparison ofthe luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. Fertil Steril. 2011;95:592-595.
17. Phy JL, Conover CA, Abbott DH, et al. Insulin and messenger ri-bonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab. 2004;89:3561-3566.
18. Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab. 2006;91:2327-2333.
19. Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Cat-teau-Jonard S. Increased anti-Mullerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril. 2010;94:198-204.
20. Legro RS, Schlaff WD, Diamond MP, et al. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab. 2010;95:5305-5313.
21. Zhang SS, Carrillo AJ, Darling DS. Expression of multiple thyroid hormone receptor mRNAs in human oocytes, cumulus cells, and granulosa cells. Mol Hum Reprod. 1997;3:555-562.
22. Ferrero H, Delgado-Rosas F, Garcia-Pascual CM, et al. Efficiency and purity provided by the existing methods for the isolation of luteinized granulosa cells: a comparative study. Hum Reprod. 2012; 27:1781-1789.
23. Petrie A, SabinC. Medical Statistics at a Glance. 1st ed. Oxford, UK: John Wiley and Sons Ltd; 2000:67-69.
24. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43-68.
25. Doody KJ, Lorence MC, Mason JI, Simpson ER. Expression ofmes-senger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J Clin Endocrinol Metab. 1990;70:1041-1045.
26. Sano Y, Suzuki K, Arai K, Okinaga S, Tamaoki BI. Changes in enzyme activities related to steroidogenesis in human ovaries during the menstrual cycle. J Clin Endocrinol Metab. 1981;52;994-1001.
27. Lan NC, Graham B, Bartter FC, Baxter JD. Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids. J Clin Endocrinol Metab. 1982;54:332-342.
28. Bureik M, Briick N, Hubel K, Bernhardt R. The human mineralo-corticoid receptor only partially differentiates between different li-gands after expression in fission yeast. FEMS Yeast Res. 2005;5: 627-633.
29. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25:947-970.
30. Tetsuka M, Thomas FJ, Thomas MJ, Anderson RA, Mason JI, Hill-ier SG. Differential expression of messenger ribonucleic acids encoding 11 /3-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. J Clin Endocrinol Metab. 1997;82:2006-2009.
31. Michael AE, Evagelatou M, Norgate DP, et al. Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol. 1997;132:43-52.
32. Thurston LM, Chin E, Jonas KC, et al. Expression of 11/3-hydrox-ysteroid dehydrogenase (11/3HSD) proteins in luteinizing human granulosa-lutein cells. JEndocrinol. 2003;178:127-135.
33. Gosden RG, Hunter RH, Telfer E, Torrance C, Brown N. Physiological factors underlying the formation of ovarian follicular fluid. J Reprod Fertil. 1988;82:813-825.
34. Evron S, Shapiro G, Diamant YZ. Induction of ovulation with spi-ronolactone (Aldactone) in anovulatory oligomenorrheic and hy-perandrogenic women. Fertil Steril. 1981;36:468-471.
35. Wenner MM, Stachenfeld NS. Blood pressure and water regulation: understanding sex hormone effects within and between men and women. J Physiol (Lond). 2012;590:5949-6591.
36. Parker CR, Rush AJ, MacDonald PC. Serum concentrations of de-oxycorticosterone in women during the luteal phase of the ovarian cycle are not suppressed by dexamethasone treatment. J Steroid Biochem. 1983;19:1313-1317.
37. Escoubet B, Couffignal C, Laisy JP, et al. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations. Circ Cardiovasc Genet. 2013;6:381-390.
38. Navot D, Margalioth EJ, Laufer N, et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril. 1987;48:57-61.
39. Manno M, Tomei F. Renin-angiotensin system activation during severe OHSS: cause or effect? Fertil Steril. 2008;89:488.
40. Strauss JFIII. The synthesis and metabolism of steroid hormones. In Strauss JF III, Barbieri RL, eds. Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 6th ed. Philadelphia: Saunders Elsevier; 2009:80-83.